Orchid

Orchid helps families have healthy babies through advanced genetic testing.

Julia and Dan's Embryo Report provides comprehensive genetic information to assist in the decision-making process during IVF, allowing individuals to confer with a genetics expert.

IVF creates multiple embryos, and Orchid helps identify the one with the fewest genetic risks by analyzing cell samples from each embryo.

Orchid offers the most advanced embryo screening, analyzing 100 times more genetic data than traditional methods. This ensures over 99% genome coverage, compared to less than 1% by other tests.

Orchid's panels include: the Neurodevelopmental Disorders (NDD) Panel screening 230+ genes, the Birth Defects Panel screening 900+ genes, and the Hereditary Cancer Panel screening 90+ genes.

Genetic counselors explain the results of the 30x Whole Genome Embryo Reports, helping parents understand each embryo's genetic information.

Orchid is backed by top embryologists and experts, such as Barry Behr and Jacques Cohen, who endorse our advancements in genetic screening.

World-class geneticists, like George Church from Harvard Medical School, support Orchid for its ability to read over 99% of an embryo's DNA and empower families with critical health information.

Orchid maximizes the chance of a successful pregnancy and a healthy child, offering superior results for various genetic conditions, outperforming alternatives in accuracy and scope.